DGX – Quest Diagnostics Incorporated
DGX — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
3.39
Margin Of Safety %
-4
Put/Call OI Ratio
0.61
EPS Next Q Diff
0.3
EPS Last/This Y
1.9
EPS This/Next Y
0.9
Price
227.99
Target Price
241.73
Analyst Recom
2.14
Performance Q
14.26
Upside
-9.0%
Beta
0.55
Ticker: DGX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-06-29 | DGX | 212.47 | 0.68 | 1.15 | 9068 |
| 2026-06-30 | DGX | 211.91 | 0.67 | 0.08 | 9059 |
| 2026-07-01 | DGX | 216.03 | 0.68 | 0.11 | 9020 |
| 2026-07-02 | DGX | 215.5 | 0.69 | 3.73 | 8949 |
| 2026-07-06 | DGX | 213.56 | 0.70 | 0.11 | 9080 |
| 2026-07-07 | DGX | 212.36 | 0.68 | 0.00 | 9347 |
| 2026-07-08 | DGX | 208.05 | 0.70 | 0.12 | 9193 |
| 2026-07-09 | DGX | 207.95 | 0.69 | 0.18 | 9249 |
| 2026-07-10 | DGX | 207.5 | 0.67 | 0.00 | 9387 |
| 2026-07-13 | DGX | 207.26 | 0.67 | 0.26 | 9343 |
| 2026-07-14 | DGX | 205.93 | 0.67 | 0.01 | 9370 |
| 2026-07-15 | DGX | 201.64 | 0.65 | 16.31 | 9546 |
| 2026-07-16 | DGX | 209.37 | 0.85 | 0.81 | 10676 |
| 2026-07-17 | DGX | 210.56 | 0.86 | 0.19 | 10720 |
| 2026-07-20 | DGX | 207.69 | 0.32 | 1.06 | 6077 |
| 2026-07-21 | DGX | 206.85 | 0.35 | 7.20 | 6409 |
| 2026-07-22 | DGX | 209.36 | 0.39 | 1.61 | 6592 |
| 2026-07-23 | DGX | 227.73 | 0.52 | 0.51 | 8109 |
| 2026-07-24 | DGX | 227.79 | 0.61 | 1.28 | 9299 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-06-29 | DGX | 212.71 | 7.7 | 8.5 | 10.77 |
| 2026-06-30 | DGX | 211.93 | 7.7 | -13.4 | 10.77 |
| 2026-07-01 | DGX | 216.03 | 7.7 | 16.1 | 10.77 |
| 2026-07-02 | DGX | 215.64 | 7.7 | -11.3 | 10.77 |
| 2026-07-06 | DGX | 213.46 | 7.7 | -22.7 | 10.77 |
| 2026-07-07 | DGX | 213.57 | 7.7 | -8.3 | 10.77 |
| 2026-07-08 | DGX | 208.12 | 7.7 | -35.2 | 10.77 |
| 2026-07-09 | DGX | 208.03 | 7.7 | -10.1 | 10.77 |
| 2026-07-10 | DGX | 207.50 | 7.8 | -12.5 | 10.77 |
| 2026-07-13 | DGX | 207.38 | 7.8 | -9.5 | 10.77 |
| 2026-07-14 | DGX | 205.92 | 7.8 | -18.0 | 10.77 |
| 2026-07-15 | DGX | 201.85 | 7.8 | -35.1 | 10.77 |
| 2026-07-16 | DGX | 209.46 | 7.8 | 40.1 | 10.77 |
| 2026-07-17 | DGX | 210.59 | 7.8 | -1.7 | 10.77 |
| 2026-07-20 | DGX | 207.69 | 7.8 | -27.5 | 10.77 |
| 2026-07-21 | DGX | 206.83 | 7.8 | -14.2 | 10.77 |
| 2026-07-22 | DGX | 210.05 | 7.8 | 11.1 | 10.77 |
| 2026-07-23 | DGX | 227.74 | 7.8 | 101.9 | 10.77 |
| 2026-07-24 | DGX | 227.99 | 7.8 | -8.5 | 10.77 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-06-29 | DGX | -12.85 | -2.33 | 3.10 |
| 2026-06-30 | DGX | -12.85 | -2.33 | 3.10 |
| 2026-07-01 | DGX | -12.85 | -2.33 | 3.10 |
| 2026-07-02 | DGX | -12.85 | -2.33 | 3.10 |
| 2026-07-06 | DGX | -12.85 | -2.26 | 3.10 |
| 2026-07-07 | DGX | -12.85 | -2.26 | 3.10 |
| 2026-07-08 | DGX | -12.85 | -2.26 | 3.10 |
| 2026-07-09 | DGX | -12.85 | -2.26 | 3.10 |
| 2026-07-10 | DGX | -12.85 | -2.26 | 3.10 |
| 2026-07-13 | DGX | -12.85 | -2.24 | 3.39 |
| 2026-07-14 | DGX | -12.85 | -2.24 | 3.39 |
| 2026-07-15 | DGX | -12.85 | -2.24 | 3.39 |
| 2026-07-16 | DGX | -12.85 | -2.24 | 3.39 |
| 2026-07-17 | DGX | -12.85 | -2.24 | 3.39 |
| 2026-07-20 | DGX | -12.85 | -2.16 | 3.39 |
| 2026-07-21 | DGX | -12.85 | -2.16 | 3.39 |
| 2026-07-22 | DGX | -12.85 | -2.16 | 3.39 |
| 2026-07-23 | DGX | -12.85 | -2.16 | 3.39 |
| 2026-07-24 | DGX | -12.85 | -2.16 | 3.39 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
2.5
Avg. EPS Est. Current Quarter
2.82
Avg. EPS Est. Next Quarter
2.8
Insider Transactions
-12.85
Institutional Transactions
-2.16
Beta
0.55
Average Sales Estimate Current Quarter
2973
Average Sales Estimate Next Quarter
3008
Fair Value
220
Quality Score
76
Growth Score
69
Sentiment Score
100
Actual DrawDown %
4.1
Max Drawdown 5-Year %
-28.6
Target Price
241.73
P/E
24.18
Forward P/E
19.13
PEG
2
P/S
2.18
P/B
3.34
P/Free Cash Flow
18.71
EPS
9.43
Average EPS Est. Cur. Y
10.77
EPS Next Y. (Est.)
11.67
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
9.15
Relative Volume
1.69
Return on Equity vs Sector %
-13.5
Return on Equity vs Industry %
2.5
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
-8.5
◆
DGX
Healthcare
$227.98
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
72.2
Range 1M
81.6%
Sup Dist
3.8%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
12.1%
EPS NY
7.9%
52W%
90.6%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+6.5% upside
Upside
+6.5%
Quality
76
MoS
-4%
DGX — P/E HistoricalDiagnostics & Research
Quest Diagnostics IncorporatedSector: Healthcare
Industry: Diagnostics & Research
Employees: 46000
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
DGX
Latest News
—
Caricamento notizie per DGX…
stock quote shares DGX – Quest Diagnostics Incorporated Stock Price stock today
news today DGX – Quest Diagnostics Incorporated stock forecast ,stock prediction 2023 2024 2025
marketwatch DGX – Quest Diagnostics Incorporated yahoo finance google finance
stock history DGX – Quest Diagnostics Incorporated invest stock market
stock prices DGX premarket after hours
ticker DGX fair value insiders trading